Koen Vandyck,Stefaan Julien Last,Ioannis Nicolaos Houpis,Pierre Jean-Marie Bernard Raboisson
申请号：
US15228720
公开号：
US20160340344A1
申请日:
2016.08.04
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Inhibitors of HCV replication of formula Iincluding stereochemically isomeric forms, and salts, solvates thereof, wherein R and R′ are, each independently, —CR1R2R3, aryl, heteroaryl or heteroC4-6cycloalkyl, whereby aryl and heteroaryl may optionally be substituted with 1 or 2 substituents selected from halo and methyl.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
